Needle | $2,200,000 | (Mar 4, 2025)
Sparta | $42,000,000 | (Mar 4, 2025)
PassEntry | $6,613,932 | (Mar 4, 2025)
Certified by Founder
Lodge
Koneksa
start up
United States
- New York
- 08/02/2022
- Series C
- $45,000,000
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
- Industry Pharmaceutical Manufacturing
- Website http://www.koneksahealth.com/
- LinkedIn https://www.linkedin.com/company/koneksa-health/
Related People
Chris BenkoFounder
United States -
New York, New York
NA
LinkedIn
https://www.linkedin.com/in/cbenko/
QRaGo | $2,830,856 | (Mar 4, 2025)
Atmosic Technologies | $40,000,000 | (Mar 4, 2025)
Koala | $15,000,000 | (Mar 4, 2025)
SkyMirr Inc | $7,300,000 | (Mar 4, 2025)
FluxGen | $3,205,440 | (Mar 4, 2025)
Actual Veggies | $7,000,000 | (Mar 4, 2025)
TakeMe2Space | $629,500 | (Mar 4, 2025)
Lizzy Care | $2,600,000 | (Mar 4, 2025)
Jurimesh | $2,000,000 | (Feb 28, 2025)